Europelab: The most advanced technologies for diagnosing Oxydative Stress

Alliance with Probiox SA

Europelab Alliance between Europelab Inc. and Probiox SA brings new Oxydative Stress profiling technologies to North-America.

Europelab Inc. and Probiox SA announced today that both companies entered into a licensing and collaboration agreement with respect to oxydative stress profiling. Under this agreement, Europelab Inc. acquires an exclusive license for North America on Probiox’ portfolio of oxydative stress profiling technologies. The agreement includes an exclusive licence to Probiox’ US patent n° 7,288,374 on a "Process for the detection of oxidative stress and kit for its implementation".

Manon Pilon, President of Europelab Inc , said : "This is a significant addition to our outstanding line of health and wellness services and cosmetic and nutraceutical products. By working with Probiox, we are now able to offer the most advanced technologies for diagnosing oxydative stress. Probiox OxyScoreTM system will be a key asset to help our customers achieve their goals of maintaining health and aging graciously. We’ll launch these new technologies through our network of CurAgeTM medical spas but we are open to work with other partners in the wellness and anti-aging field throughout North-America and the Caribbean."

Dr.Chalom Sayada, President of Probiox SA, commented : "We are very excited to work with Europelab Inc. It is a great partner to take our line of oxydative stress profiling products to the North-American market. In addition to their excellent network for offering services to a health-conscious clientele, we will also jointly approach nutraceutical companies throughout North-America eager to scientifically validate the health benefits of their products. I am convinced that the American market will respond very favourably to our OxygenesTM micro-array technology, which is already being used in a significant number of clinical studies with a view to underpin health claims under the new European regulation."

According to Prof. Luc Montagnier, winner of the 2008 Noble Prize for Medicine, managing oxydative stress is a key factor to maintain health and prevent disease. Prof. Montagnier, co-founder of Probiox, said : "Oxydative stress is all too often neglected or poorly diagnosed. I am pleased to see that reliable methods for diagnosing oxydative stress are gaining recognition and will now benefit the North-American public and nutraceutical sector."